Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
An Interview With Christoph van Eickels, Dr. Deepak Venkanna, and Holly Olmstead
Executive Q&A topic: Regulatory Requirements for Upstream Bioprocess Solutions read more
Horizon Lines: A Quarterly Review of NDAs – July-September 2025
This quarterly review on New Drug Applications contains data for applications approved during the third quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 48 applications were approved by the FDA during these three months. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma
Monday, May 18, 2026
LOTTE Biologics announced an expansion of its collaboration with Ottimo Pharma, a biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic ... read more
Avid Bioservices Appoints Chief People Officer
Monday, May 18, 2026
Avid Bioservices announced the appointment of Maria Ebro Andreasen as Chief People Officer. The appointment comes as Avid continues to scale its ... read more
Catalent and Elpida Therapeutics Enter Strategic Partnership for Late-Phase AAV Manufacturing
Monday, May 18, 2026
Elpida Therapeutics, a non-profit biotechnology company developing gene therapies for ultra-rare diseases, and Catalent announced a strategic ... read more
Piramal Pharma Solutions Partners with Botanix to Support Drug Substance Development
Monday, May 18, 2026
Piramal Pharma Solutions has entered a manufacturing and supply arrangement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, a ... read more
Agilent and Veeda Lifesciences Collaborate to Accelerate GLP-1 and Complex Biologics Development Services
Thursday, May 14, 2026
Agilent Technologies announced a strategic collaboration with Veeda Lifesciences to strengthen regulatory-aligned analytical and bioanalytical ... read more